Mutant p53 Gain of Function in Two Mouse Models of Li-Fraumeni Syndrome: Cell
Mutant p53 elicits context-dependent pro-tumorigenic phenotypes | Oncogene
Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options - ScienceDirect
Prognostic value of TP53 mutation location in breast cancer | CMAR
Mutations of the p53 Gene as a Prognostic Factor in Aggressive B-Cell Lymphoma | NEJM
p53 Is the Most Frequently Mutated Gene in Cancer, but Can We Target It?
Gain of function in somatic TP53 mutations is associated with immune‐rich breast tumors and changes in tumor‐associated macrophages - Behring - 2019 - Molecular Genetics & Genomic Medicine - Wiley Online Library
Mutant p53 achieved Gain-of-Function by promoting tumor growth and immune escape through PHLPP2/AKT/PD-L1 pathway
Frontiers | Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies
Targeting a neoantigen derived from a common TP53 mutation | Science
Biomolecules | Free Full-Text | p53's Extended Reach: The Mutant p53 Secretome
A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer - Frontiers
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis | Nature Communications
TP53 mutations predict poor response to immunotherapy in patients with metastatic solid tumors - Kim - 2023 - Cancer Medicine - Wiley Online Library
Overall survival curves of patients with p53 mutation results. (A) p53... | Download Scientific Diagram
Cancers | Free Full-Text | TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes
Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis | Cell Death Discovery
Omics analyses of a somatic Trp53R245W/+ breast cancer model identify cooperating driver events activating PI3K/AKT/mTOR signaling | PNAS
Implications of driver genes associated with a high tumor mutation burden identified using next‑generation sequencing on immunotherapy in hepatocellular carcinoma
Frequency of p53 mutations in human cancers. (A) Schematic picture... | Download Scientific Diagram
Acetylation halts missense mutant p53 aggregation and rescues tumor suppression in non-small cell lung cancers - ScienceDirect
The p53 network: cellular and systemic DNA damage responses in cancer and aging: Trends in Genetics
Survival of patients with p53 mutations in the DNA-binding motifs... | Download Scientific Diagram
LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma
Evaluating the prognostic significance of p53 and TP53 mutations in HPV-negative hypopharyngeal carcinoma patients: a 5-year follow-up retrospective study | BMC Cancer | Full Text
TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions | eLife
p53 Is the Most Frequently Mutated Gene in Cancer, but Can We Target It?
